Immunome
IMNM
IMNM
57 hedge funds and large institutions have $230M invested in Immunome in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% more funds holding
Funds holding: 35 → 57 (+22)
30.95% more ownership
Funds ownership: 19.37% → 50.32% (+31%)
Holders
57
Holding in Top 10
1
Calls
$806K
Puts
$152K
Top Buyers
| 1 | +$41.8M | |
| 2 | +$41.5M | |
| 3 | +$41.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.4M |
Top Sellers
| 1 | -$1.86M | |
| 2 | -$693K | |
| 3 | -$326K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$152K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$130K |